---

---

symbols : Bmy   

save search

---

Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -0.5% | O: -0.5% H: 0.0% C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M |

Health Technology

| 0.06% | O: 0.06% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| -0.27% | O: -0.27% H: 0.0% C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M |

Health Technology

| -0.18% | O: -0.18% H: 0.0% C: 0.0%
research global antiviral market

---

Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| -0.27% | O: -0.27% H: 0.0% C: 0.0%
reblozyl for chmp positive

---

Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| -0.27% | O: -0.27% H: 0.0% C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M |

Health Technology

| -0.57% | O: -0.57% H: 0.0% C: 0.0%
treatment for chmp psoriasis positive

---

Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published: 2023-01-26 (Crawled : 18:00) - prnewswire.com
NVSEF | News 4 d | $90.0 0 |

Health Technology

| -1.1% | O: -1.1% H: 0.0% C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -3.0% | O: -1.25% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.42% | O: 0.7% H: 0.0% C: 0.0%
REGN | News | $742.84 0.07% 0.07% 410K |

Health Technology

| 1.96% | O: 1.46% H: 0.0% C: 0.0%
global report roche market

---

Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Published: 2023-01-26 (Crawled : 13:20) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.42% | O: 0.7% H: 0.0% C: 0.0%
breyanzi leukemia trial response transcend

---

Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | News | $16.03 -0.43% 0.0% 3.7M |

Health Technology

| -0.68% | O: 0.03% H: 0.0% C: 0.0%
NVO | $138.09 0.4% 1.38% 1.1M |

Health Technology

| -1.59% | O: 0.14% H: 0.0% C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -2.98% | O: 0.0% H: 0.0% C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -1.86% | O: -1.45% H: 0.0% C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M |

Health Technology

| 0.37% | O: 0.23% H: 0.0% C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M |

Health Technology

| -3.14% | O: -1.35% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.05% | O: 0.19% H: 0.0% C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M |

Health Technology

| -3.18% | O: -2.16% H: 0.0% C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M |

Health Technology

| -2.51% | O: -0.92% H: 0.0% C: 0.0%
GILD F | $83.7 0.1% 0.1% 4.1M |

Health Technology

| -0.14% | O: 0.43% H: 0.0% C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M |

Health Technology

| -3.58% | O: -0.9% H: 0.0% C: 0.0%
global report growth market

---

Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published: 2023-01-18 (Crawled : 19:00) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -2.98% | O: 0.0% H: 0.0% C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -1.86% | O: -1.45% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.05% | O: 0.19% H: 0.0% C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M |

Health Technology

| -2.51% | O: -0.92% H: 0.0% C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M |

Health Technology

| -3.58% | O: -0.9% H: 0.0% C: 0.0%
research report growth market

---

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
PFE | $43.79 -1.04% 0.0% 23M |

Health Technology

| -7.56% | O: -2.74% H: 0.0% C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -2.81% | O: 0.51% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.65% | O: 1.94% H: 0.52% C: -1.09%
ABT | News | $109.95 -1.01% 0.0% 4.9M |

Health Technology

| -0.56% | O: 2.05% H: 0.69% C: -0.1%
SNY | News | $48.49 -0.66% -0.66% 1.1M |

Health Technology

| -1.56% | O: 1.1% H: 0.22% C: 0.02%
GILD F | $83.7 0.1% 0.1% 4.1M |

Health Technology

| -2.14% | O: 0.7% H: 0.37% C: -0.74%
hepatitis global antiviral hiv therapeutics growth market

---

Charles LaPree
Published: 2023-01-12 (Crawled : 21:00) - savarapharma.com
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -3.99% | O: -0.83% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.33% | O: -0.36% H: 0.37% C: -0.11%

---

Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
Published: 2023-01-11 (Crawled : 14:00) - biospace.com/
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -3.98% | O: 0.01% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 2.27% | O: 0.32% H: 0.66% C: 0.6%
WBA | $37.17 1.84% 1.8% 5.9M |

Retail Trade

| 0.34% | O: 2.27% H: 0.24% C: -0.22%
GERN | $3.35 -0.59% -0.6% 3.6M |

Health Technology

| 15.02% | O: 11.95% H: 0.0% C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M |

Health Technology

| -6.26% | O: 1.54% H: 0.0% C: 0.0%
for commercial

---

CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -1.9% | O: 1.97% H: 0.0% C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M |

Health Technology

| -3.85% | O: 1.12% H: 0.27% C: -3.89%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.76% | O: 1.06% H: 0.05% C: -2.89%
BNTX | $143.69 0.81% 0.8% 440K |

Health Technology

| -3.38% | O: 2.93% H: 0.0% C: 0.0%
research car-t therapy market

---

Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
Published: 2023-01-06 (Crawled : 14:20) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -1.82% | O: 0.08% H: 0.0% C: 0.0%
GE | $83.23 2.58% -0.08% 7.8M |

Electronic Technology

| 15.91% | O: 3.1% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.46% | O: 0.7% H: 0.0% C: 0.0%
BPMC | $47.79 0.08% 0.08% 280K |

Health Technology

| 0.32% | O: -1.78% H: 0.0% C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M |

Health Technology

| -3.22% | O: 2.43% H: 0.0% C: 0.0%

---

Hestia Insight Inc. Appoints Advisory Board Member to Assist in Company Growth
Published: 2023-01-05 (Crawled : 12:20) - globenewswire.com
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.66% | O: -0.79% H: 0.0% C: 0.0%
growth

---

Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GSK | News | $35.3 -0.11% 0.14% 3.5M |

Health Technology

| -0.67% | O: -2.81% H: 0.0% C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M |

Health Technology

| -4.8% | O: -0.69% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.66% | O: -0.79% H: 0.0% C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M |

Health Technology

| -10.05% | O: -0.39% H: 0.0% C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M |

Health Technology

| -1.5% | O: -3.07% H: 0.0% C: 0.0%
global active report teva market

---

Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.98% | O: -0.58% H: 0.0% C: 0.0%
conference

---

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.98% | O: -0.58% H: 0.0% C: 0.0%

---

Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
PFE | $43.79 -1.04% 0.0% 23M |

Health Technology

| -13.95% | O: 0.02% H: 0.0% C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M |

Health Technology

| -2.39% | O: -0.03% H: 0.0% C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -5.05% | O: -0.01% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 1.11% | O: 0.13% H: 0.0% C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M |

Health Technology

| -0.08% | O: -0.39% H: 0.0% C: 0.0%
GILD F | $83.7 0.1% 0.1% 4.1M |

Health Technology

| -1.92% | O: -0.12% H: 0.0% C: 0.0%
EXEL M | $17.48 -1.3% -1.32% 1.6M |

Health Technology

| 13.09% | O: 0.03% H: 0.0% C: 0.0%
AZN | $65.54 -0.68% -0.69% 3.1M |

Health Technology

| -3.1% | O: -0.5% H: 0.0% C: 0.0%
global disease report therapeutics cancer market

---

Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published: 2022-12-28 (Crawled : 21:00) - prnewswire.com
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M |

Health Technology

| -5.29% | O: -0.26% H: 0.42% C: 0.01%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| 0.16% | O: -0.66% H: 0.47% C: -0.28%
GILD F | $83.7 0.1% 0.1% 4.1M |

Health Technology

| -2.29% | O: -0.78% H: 0.78% C: 0.41%

---

Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
Published: 2022-12-16 (Crawled : 12:00) - biospace.com/
EVO | $10.34 1.55% 9.7K |

Manufacturing

| 24.73% | O: -1.69% H: 0.0% C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| -5.14% | O: -3.19% H: 0.0% C: 0.0%
collaboration

---

Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
Published: 2022-12-15 (Crawled : 13:00) - biospace.com/
BMY | News | $72.45 -0.74% 0.0% 5.4M |

Health Technology

| -6.39% | O: -1.32% H: 0.0% C: 0.0%
report for results

---

Gainers vs Losers

66%

34%

Top 10 Gainers

---

Your saved searches

---